Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Comparison of two physiotherapy rehabilitation programmes on the exercise capacity in patients with severe pulmonary hypertension
ISRCTN ISRCTN06900747
ClinicalTrials.gov identifier
Public title Comparison of two physiotherapy rehabilitation programmes on the exercise capacity in patients with severe pulmonary hypertension
Scientific title Comparison of two physiotherapy rehabilitation programmes on the exercise capacity in patients with severe pulmonary hypertension: a randomised study
Acronym Rehab PH
Serial number at source EKBB 200/09
Study hypothesis An endurance or/and resistance training improves the exercise capacity and quality of life of patients with severe pulmonary hypertension
Lay summary
Ethics approval The local ethics committee, Basel, Switzerland approved in June 2009
Study design Prospective randomised interventional trial
Countries of recruitment Switzerland
Disease/condition/study domain Pulmonary hypertension
Participants - inclusion criteria 1. Patients with pulmonary hypertension diagnosed by right heart catheterisation (mean pulmonary pressure [PAPm] > 25 mmHg)
2. New York Heart Association (NYHA) III - V
3. Walking distance (6-minutes walk test) > 150 meters
4. Patients with stable conditions on PH-related medication (single, double or triple therapy)
5. In stable condition for at least 3 months
Participants - exclusion criteria 1. Skeletal or muscular restrictions which make the training impossible
2. New occurrence of syncope
3. Concomitant neurological diseases
4. Patients with neoplastic diseases
5. Mental disability making a proper evaluation of the study impossible
6. Age > 18 years < 85
7. Rapid fatal disease
Anticipated start date 01/07/2010
Anticipated end date 30/06/2012
Status of trial Ongoing
Patient information material Not available in web format, please use contact details below to request a patient information sheet.
Target number of participants 36
Interventions Intervention group 1: - endurance training: twice a week, 60 minutes, over 12 weeks
Intervention group 2: - resistance training: twice a week, 60 minutes, over 12 weeks
Primary outcome measure(s) Change in walking distance (6-minutes walk test) after 12 weeks of training and 12 weeks follow up
Secondary outcome measure(s) 1. Change in VO2 submax (mobile spiroergometry) after 12 weeks of training and 12 weeks follow up
2. Change in scores for quality of life (SF-36 questionnaire) after 12 weeks of training and 12 weeks follow up
3. Change in scores (MRC-Dyspnoea scale) after 12 weeks of training and 12 weeks follow up
4. Change in daily activity measured with an accelerometer AiperMotion 320 after 12 weeks of training and 12 weeks follow up
Sources of funding University Hospital Basel (Switzerland) - Clinic of Pneumology and Respiratory Cell Research (from research funds of Prof M Tamm)
Trial website
Publications
Contact name Prof  Daiana  Stolz
  Address University Hospital Basel
Pneumology
Petersgraben 4
  City/town Basel
  Zip/Postcode 4031
  Country Switzerland
Sponsor University Hospital Basel (Switzerland)
  Address University Hospital Basel
Pneumology
Petersgraben 4
  City/town Basel
  Zip/Postcode 4031
  Country Switzerland
Date applied 27/05/2010
Last edited 15/07/2010
Date ISRCTN assigned 15/07/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central